Why PatientCentra?

Given the number of clinical trials that are behind on target enrollment goals and timelines, it’s clear that new approaches are needed for patient recruitment. Patients are routinely inundated with untargeted information, unclear clinical trial value propositions and a lack of a patient-centric approach. Additionally, too many unqualified patients are often sent to overwhelmed sites, leaving both sites and patients frustrated and unable to move through the process efficiently and effectively.

PatientCentra leverages a different approach, where digitally-enabled, carefully planned and monitored patient journeys serve as a model for reinventing patient recruitment. Our unrivaled digital experience and unique tools have helped more than a million patients through our tailored, patient-centered process. Let us show you how we can apply this proven, effective approach for your patient recruitment and enrollment needs.

PatientCentra goes well beyond just generating patient interest or even providing initial patient pre-qualification. Leveraging both people and technology (including our proprietary Performance Portal™ Patient Tracking & Management System), we provide a coordinated system of personal follow-up and support for patients. Our System ensures patients are properly informed, educated, qualified, and efficiently moved through the pipeline to trial enrollment. Of particular focus is the downstream funnel management (past online pre-screening and all the way through to final patient disposition) where call center and investigator site response follow-up are key to maximizing the throughput of qualified patients. The end result is a seamless process for patients and a more efficient one for sponsors and sites.

See how our end-to-end process tripled the online pre-screened to randomized patient conversion for a top 5 pharma client.

Case Study

"Top 5" Pharma Company Triples Conversions

A top 5 pharmaceutical company worked with PatientCentra to recruit for two phase II diabetes clinical trials.  The initial program produced 18 randomized patients (~20% of total randomization requirement) in just three months.  Despite good results, sponsor and PatientCentra determined that ‘downstream conversion’ (from Online Pre-Screened patients to Randomized patients) could be improved.   PatientCentra embarked on a series of initiatives for the next, similar, phase II diabetes clinical trial with the following results:

• Implemented over 15 different Site, Call Center and Patient enablement strategies
• Increase downstream conversion by more than 3X
• Produced 20 Randomizations from nearly a third of the initial patient leads

To see the full case study and learn how PatientCentra can help resolve your clinical trial enrollment challenges, please contact us directly

Dismiss

PatientCentra has the experience and regulatory infrastructure to support your global patient recruitment needs. We have executed digitally-enabled patient recruitment programs on 5 different continents including North America, South America, Europe, Australia and Asia (including Japan and China). We are certified through a leading data privacy consultancy to ensure our practices comply with global data privacy regulations including HIPAA/HITECH (US), GDPR (EU), PIPEDA (Canada), CBPR (APEC), APPs (Australia), APPI (Japan), China CSL and more.

At PatientCentra, we put our money where our mouth is…with performance-based pricing models where a significant portion of program fees are only incurred once we produce pre-screened and enrolled/randomized patients. We don’t produce, you don’t pay. And just as importantly, we mix this low risk approach to pricing with an ability to produce results at scale. Our programs often contribute up to (or more than) 20% of a clinical trial’s randomization target. We include projected enrollment contributions and pro forma cost estimates on a monthly basis, so you’ll always know what to expect, and when to expect it.